Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
/DISREGARD RELEASE: HanAll Biopharma and Daewoong Pharmaceutical/ 2022-04-12 15:34
PharmAbcine Presents Updated Preclinical Data of Its Anti-VISTA Antibody Candidate at AACR 2022 2022-04-11 20:00
OliX Pharmaceuticals Identifies Inhibition of Target Gene Expression in Nonhuman Primate Models for NASH Candidate 2022-04-08 20:00
AGC to Expand Synthetic Pharmaceutical Production Base in Spain 2022-04-08 14:00
CARsgen Appoints Dr. Raffaele Baffa as Chief Medical Officer 2022-04-07 23:42
REDCLOUD BIO TO PRESENT PRECLINICAL DATA OF NEXT-GENERATION EGFR TKI H002 AT ANNUAL MEETING OF AMERICAN ASSOCIATION OF CANCER RESEARCH 2022-04-07 19:47
Psychobiotic PS128 Registration, Health Claims Approved in Thailand, Canada 2022-04-07 11:20
Alterity Therapeutics Announces Presentation of bioMUSE Data at the American Academy of Neurology (AAN) Annual Meeting 2022-04-07 09:34
ENSEM Therapeutics, a CBC Group-Incubated Biopharma Company, Raises $67 Million in Series A Financing to Develop Small Molecule Medicines for Difficult-to-Drug Targets 2022-04-07 04:00
HitGen and UPPTHERA Extend PROTAC Research Collaboration after Hit Finding Success on Undruggable Targets 2022-04-06 22:30
Volition appoints Sharon Ballesteros as U.S. Head of Quality and Development Process 2022-04-06 20:00
Kintor Pharma's Proxalutamide Demonstrated Reduction in Hospitalization/Mortality for Patients with Mild to Moderate COVID-19 in Phase III MRCT Study 2022-04-06 09:22
Nihon Medi-Physics Attains World's First Manufacturing of Actinium-225 with Cyclotron on Production Scale for Investigational Drugs 2022-04-05 16:00
Indonesia's Ministry of Health Discussed a Universal Vaccine Passport and Verifier for International Travelers 2022-04-04 23:35
Dada's JDDJ in action to guarantee medical supply and online health consultation with pharmaceutical partners 2022-04-02 20:53
Zhongze Therapeutics Announces Successful Completion Of The First-In-Human Dose Escalation Study of ZZ6398 in Healthy Volunteers 2022-04-01 16:55
Akeso Reported 2021 Annual Results 2022-04-01 13:44
Zhimeng Biopharma Announces Dosing of First Subject in First-in-Human Phase -- Clinical Trial of CB06 2022-03-31 23:40
Aceemzyme Co., Ltd., challenging to new drug of brain diseases with recombinase-based ginsenoside Rh2 (s) mass production technology… 2022-03-31 21:00
I-Mab Announces Voluntary Lock-ups by Key Shareholders and Senior Management for Long-Term Commitment 2022-03-31 20:00
1 80 81 82 83 84 165